| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/24/2013 | US20130024988 Variety Corn Line NPFX6247 |
| 01/24/2013 | US20130024987 Variety Corn Line NPFB7193 |
| 01/24/2013 | US20130024986 Transgenic plants with controlled distribution of a trait to progeny |
| 01/24/2013 | US20130024984 Lettuce Cultivar Gaviota |
| 01/24/2013 | US20130024963 Pepper hybrid ps11447353 |
| 01/24/2013 | US20130024962 Pepper Hybrid E 490264 |
| 01/24/2013 | US20130024961 Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs |
| 01/24/2013 | US20130024960 Optimised coding sequence and promoter |
| 01/24/2013 | US20130024959 Conditional expression of transgenes in vivo |
| 01/24/2013 | US20130024958 Lentiviral vectors that provide improved expression and reduced variegation after transgenesis |
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130024955 Method for determining genotoxicity using non-fluorescent proteins |
| 01/24/2013 | US20130023654 Antibodies to matrix metalloproteinase 9 |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023643 Nuclear localization signal peptides derived from vp2 protein of chicken anemia virus and uses of said peptides |
| 01/24/2013 | US20130023580 Compositions and Methods for Inhibiting Expression of XBP-1 Gene |
| 01/24/2013 | US20130023578 siRNA for inhibition of c-Met expression and anticancer composition containing the same |
| 01/24/2013 | US20130023577 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES |
| 01/24/2013 | US20130023565 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
| 01/24/2013 | US20130023481 Adenovirus E1A Fragments for Use in Anti-Cancer Therapies |
| 01/24/2013 | US20130023478 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 01/24/2013 | US20130023477 Growth hormone fusion proteins |
| 01/24/2013 | US20130023474 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/24/2013 | US20130023461 Oligopeptide compounds and uses thereof |
| 01/24/2013 | US20130023446 siRNA Targeting Beta Secretase (BACE) |
| 01/24/2013 | US20130023442 Single nucleotide polymorphism for predicting recurrence of hepatocellular carcinoma |
| 01/24/2013 | US20130023421 Protein display |
| 01/24/2013 | US20130023416 Methods and compositions to produce rice resistant to accase inhibitors |
| 01/24/2013 | US20130023053 Methods and compositions for targeted mutagenesis in bacteria |
| 01/24/2013 | US20130023052 Manipulator system and manipulation method of micromanipulation target object |
| 01/24/2013 | US20130023051 Techniques for transfecting protoplasts |
| 01/24/2013 | US20130023047 Nucleic Acids Encoding Humanized Anti-CD40 Antibodies |
| 01/24/2013 | US20130023036 Nucleic acid construct, recombinant vector, and recombinant e. coli producing chicken anemia virus vp1 protein |
| 01/24/2013 | US20130023034 Mutated rep encoding sequences for use in aav production |
| 01/24/2013 | US20130023033 Pharmacologically induced transgene ablation system |
| 01/24/2013 | US20130023032 Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof |
| 01/24/2013 | US20130023030 Recovery of recombinant human parainfluenza virus type 2 (hypiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 01/24/2013 | US20130023029 Novel asparaginases and uses thereof |
| 01/24/2013 | US20130023028 Variants Of A Polypeptide With Lipolytic Activity and Improved Stability |
| 01/24/2013 | US20130023022 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 01/24/2013 | US20130023021 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 01/24/2013 | US20130023017 Method for producing pyripyropene |
| 01/24/2013 | US20130023016 L-ornithine or l-arginine producing strain and method for producing l-ornithine or l-arginine |
| 01/24/2013 | US20130023014 Novel cellulase gene |
| 01/24/2013 | US20130023012 Recombinase-Based Methods for Producing Expression Vectors and Compositions for Use in Practicing the Same |
| 01/24/2013 | US20130023009 Method for specifically producing a joined dna fragment comprising a sequence derived from a target gene |
| 01/24/2013 | US20130023004 Fluorogenic substrate for adamts13 |
| 01/24/2013 | US20130022999 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/24/2013 | US20130022989 Dental stem cell reprogramming |
| 01/24/2013 | US20130022983 Colon and Rectal Tumor Markers and Methods of Use Thereof |
| 01/24/2013 | US20130022979 3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER |
| 01/24/2013 | US20130022967 NUCLEIC ACID MOLECULE HAVING AFFINITY TO RODENT-DERIVED IgG ANTIBODY, BINDER, DETECTION REAGENT, AND DETECTION KIT |
| 01/24/2013 | US20130022964 Use of Ribozymes in the Detection of Adventitious Agents |
| 01/24/2013 | US20130022724 Lettuce sister lines px06514083, px06514153, px06514201 and px06514204 |
| 01/24/2013 | US20130022707 Grain quality through altered expression of seed proteins |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022639 Expression of meningococcal fhbp polypeptides |
| 01/24/2013 | US20130022634 New composition and methods for treatment of autoimmune and allergic diseases |
| 01/24/2013 | US20130022633 MENINGOCOCCAL fHBP POLYPEPTIDES |
| 01/24/2013 | US20130022632 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
| 01/24/2013 | US20130022631 Vaccine for chikungunya virus infection |
| 01/24/2013 | US20130022624 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 01/24/2013 | US20130022620 Assays and methods pertaining to pre-amyloid intermediates |
| 01/24/2013 | US20130022617 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 01/24/2013 | US20130022616 Interleukin-31 Monoclonal Antibody |
| 01/24/2013 | US20130022606 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/24/2013 | US20130022605 Antagonists against tnfr1 and methods of use therefor |
| 01/24/2013 | US20130022604 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 01/24/2013 | US20130022603 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
| 01/24/2013 | US20130022602 Methods and compositions to modulate antiviral and immune activity responses |
| 01/24/2013 | US20130022601 Trivalent, bispecific antibodies |
| 01/24/2013 | US20130022597 Antibodies Directed To GPNMB And Uses Thereof |
| 01/24/2013 | US20130022595 Variants of humanized immunomodulatory monoclonal antibodies |
| 01/24/2013 | US20130022590 Compositions Comprising Zinc Finger Domains and Uses Therefor |
| 01/24/2013 | DE112011100940T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation |
| 01/24/2013 | DE112010001705T5 RNA-vermittelte lnduktion von Genexpression in Pflanzen RNA-mediated induction of gene expression in plants |
| 01/24/2013 | DE102011054474A1 System zur Stabilisierung, Aufbewahrung und Lagerung einer Nukleinsäure System for stabilization, preservation and storage of a nucleic acid |
| 01/24/2013 | CA2842169A1 Anti-cxcr4 antibodies and methods of use |
| 01/24/2013 | CA2842067A1 Novel il-17r-ecd mutants |
| 01/24/2013 | CA2842055A1 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
| 01/24/2013 | CA2841994A1 Compositions and methods for immunomodulation |
| 01/24/2013 | CA2841782A1 Methods of increasing yield and stress tolerance in a plant |
| 01/24/2013 | CA2841745A1 Rspo binding agents and uses thereof |
| 01/24/2013 | CA2841710A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | CA2841164A1 Attenuated plasmodium with deactivated hmgb2 gene, as vaccine |
| 01/24/2013 | CA2841060A1 Method and kit for dna typing of hla gene |
| 01/24/2013 | CA2840934A1 Plants resistant to insect pests |
| 01/24/2013 | CA2840925A1 Down-regulating gene expression in insect pests |
| 01/24/2013 | CA2840505A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/24/2013 | CA2839593A1 Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites |
| 01/24/2013 | CA2839028A1 Novel plant terminator sequences |
| 01/23/2013 | EP2548968A1 Method of producing astaxanthin by fermentation |
| 01/23/2013 | EP2548964A2 Compositions and methods for the suppression of target polynucleotides from Lepidoptera |
| 01/23/2013 | EP2548963A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/23/2013 | EP2548962A1 Sirna sequence-independent modification formats for reducing off-target phenotypic effects in rnai, and stabilized forms thereof |
| 01/23/2013 | EP2548961A1 Method for determination of progression risk of glaucoma |
| 01/23/2013 | EP2548960A1 Nucleic acids comprising formula (NuGIXmGnNv)a and derivatives thereof as an immunostimulating agents/adjuvant |
| 01/23/2013 | EP2548959A1 Florigen-activating complex |
| 01/23/2013 | EP2548958A1 Agent for improving gene transfer efficiency to mammalian cells |
| 01/23/2013 | EP2548957A1 Method for producing kluyveromyces marxianus transformant |